Foresite Capital Management V, LLC Diversified Active

CIK: 0001792206 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 11, 2023

Total Value ($000): $136,902 (100.0% shares, 0.0% debt)

Holdings (10)

HIMS Hims & Hers Health, Inc. 25.6%
Value ($000) $35,094 Shares 3,733,381 Est. Cost $8.43 Unrealized +17.6%
— Theseus Pharmaceuticals, Inc. 24.4%
Value ($000) $33,451 Shares 3,585,346 Est. Cost $11.90 Unrealized —
— Pardes Biosciences Inc 14.3%
Value ($000) $19,570 Shares 10,811,887 Est. Cost $14.46 Unrealized —
ACRS Aclaris Therapeutics, Inc. 9.5%
Value ($000) $13,048 Shares 1,258,243 Est. Cost $19.56 Unrealized -53.7%
IRON Disc Medicine, Inc. 7.9%
Value ($000) $10,812 Shares 243,513 Est. Cost $49.79 Unrealized -28.7%
— Kinnate Biopharma Inc. 7.8%
Value ($000) $10,684 Shares 3,525,957 Est. Cost $13.15 Unrealized —
— Somalogic, Inc. 5.7%
Value ($000) $7,862 Shares 3,403,276 Est. Cost $12.39 Unrealized —
CMPX Compass Therapeutics, Inc. 3.1%
Value ($000) $4,211 Shares 1,324,071 Est. Cost $3.29 Unrealized -4.5%
QSI Quantum Si Inc 1.2%
Value ($000) $1,655 Shares 924,404 Est. Cost $10.48 Unrealized -85.0%
PHVS Pharvaris N.V. 0.4%
Value ($000) $517 Shares 34,142 Est. Cost $31.46 Unrealized -69.4%